Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Alyateem

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Endocrinology|March 18, 2021
Current Status and Future Targeted Therapy in Adrenocortical CancerGeorge Alyateem, Naris Nilubol
Scientific Reports|July 10, 2024
A whole-genome CRISPR screen identifies the spindle accessory checkpoint as a locus of nab-paclitaxel resistance in a pancreatic cancer cell linePriya Mondal, George Alyateem, Allison V Mitchell, et al.
Current Cancer Drug Targets|April 25, 2020
The Evolving AML Genomic Landscape: Therapeutic ImplicationsSachi Horibata, George Alyateem, Christin B DeStefano, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2024
A whole-genome CRISPR screen identifies the spindle accessory checkpoint as a locus of nab-paclitaxel resistance in pancreatic cancer cellsPriya Mondal, George Alyateem, Allison V Mitchell, et al.
Journal of Vascular Surgery|August 22, 2018
Comparison of commercially available versus customized branched-fenestrated devices in the treatment of complex aortic aneurysmsFernando Motta, Raghuveer Vallabhaneni, Corey A Kalbaugh, et al.
Cancer Gene Therapy|April 7, 2023
Use of CRISPR-based screens to identify mechanisms of chemotherapy resistanceGeorge Alyateem, Heidi M Wade, Aaron A Bickert, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Endocrinology|March 18, 2021
Current Status and Future Targeted Therapy in Adrenocortical CancerGeorge Alyateem, Naris Nilubol
Scientific Reports|July 10, 2024
A whole-genome CRISPR screen identifies the spindle accessory checkpoint as a locus of nab-paclitaxel resistance in a pancreatic cancer cell linePriya Mondal, George Alyateem, Allison V Mitchell, et al.
Current Cancer Drug Targets|April 25, 2020
The Evolving AML Genomic Landscape: Therapeutic ImplicationsSachi Horibata, George Alyateem, Christin B DeStefano, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2024
A whole-genome CRISPR screen identifies the spindle accessory checkpoint as a locus of nab-paclitaxel resistance in pancreatic cancer cellsPriya Mondal, George Alyateem, Allison V Mitchell, et al.
Journal of Vascular Surgery|August 22, 2018
Comparison of commercially available versus customized branched-fenestrated devices in the treatment of complex aortic aneurysmsFernando Motta, Raghuveer Vallabhaneni, Corey A Kalbaugh, et al.
Cancer Gene Therapy|April 7, 2023
Use of CRISPR-based screens to identify mechanisms of chemotherapy resistanceGeorge Alyateem, Heidi M Wade, Aaron A Bickert, et al.
Pageof 1